Ventyx Biosciences, Inc. VTYX

Full chart Compare
Set alert

Price alert · VTYX

All alert types
14.00 USD 0.00 (+0.00%)

Mar 6, 2026, 9:30 AM EST

14.00 Day range 14.00

52-week range unavailable

YTD
+55.04%
1 year
+858.90%

Financial health

Altman Z-Score

25.22 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.1×
FY 2019: -9.2×FY 2020: -37.5×FY 2021: -11.8×FY 2022: -15.9×FY 2023: -0.7×FY 2024: -1.1×
FY 2019 5y median -11.8× FY 2024
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
P/B 0.6×
FY 2019: -10.0×FY 2020: -34.5×FY 2021: 3.6×FY 2022: 4.9×FY 2023: 0.6×FY 2024: 0.6×
FY 2019 5y median 0.6× FY 2024
P/FCF -1.1×
FY 2019: -15.6×FY 2020: -171×FY 2021: -25.7×FY 2022: -17.4×FY 2023: -0.9×FY 2024: -1.1×
FY 2019 5y median -17.4× FY 2024
EV/EBITDA -1.0×
FY 2019: -44673×FY 2020: 0.0×FY 2021: -11.1×FY 2022: -15.4×FY 2023: -0.5×FY 2024: -1.0×
FY 2019 5y median -1.0× FY 2024
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
FCF Yield -87.4%
FY 2019: -6.4%FY 2020: -0.6%FY 2021: -3.9%FY 2022: -5.8%FY 2023: -115.5%FY 2024: -87.4%
FY 2019 5y median -5.8% FY 2024

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
ROE -53.2%
FY 2019: 108.4%FY 2020: 91.9%FY 2021: -30.0%FY 2022: -30.6%FY 2023: -79.1%FY 2024: -53.2%
FY 2019 5y median -30.6% FY 2024
ROIC -56.1%
FY 2019: 1482.3%FY 2020: 608.8%FY 2021: -24.0%FY 2022: -31.8%FY 2023: -81.1%FY 2024: -56.1%
FY 2019 5y median -31.8% FY 2024
ROA -48.9%
FY 2019: -1281.7%FY 2020: -11499.6%FY 2021: -28.7%FY 2022: -29.2%FY 2023: -69.5%FY 2024: -48.9%
FY 2019 5y median -48.9% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 FY 2024
Operating Income 28.6%
FY 2019: 0.0%FY 2020: -68.7%FY 2021: -852.4%FY 2022: -68.5%FY 2023: -83.8%FY 2024: 28.6%
FY 2019 FY 2024
EPS (diluted) 40.3%
FY 2019: 0.0%FY 2020: 75.5%FY 2021: -201.8%FY 2022: -21.9%FY 2023: -60.2%FY 2024: 40.3%
FY 2019 FY 2024
Free Cash Flow 21.5%
FY 2019: 0.0%FY 2020: -134.5%FY 2021: -528.1%FY 2022: -154.5%FY 2023: -68.6%FY 2024: 21.5%
FY 2019 FY 2024

Financial Health

Current Ratio 18.0×
FY 2019: 0.6×FY 2020: 0.2×FY 2021: 21.4×FY 2022: 20.2×FY 2023: 11.9×FY 2024: 18.0×
FY 2019 5y median 18.0× FY 2024
Quick Ratio 18.0×
FY 2019: 0.6×FY 2020: 0.2×FY 2021: 21.4×FY 2022: 20.2×FY 2023: 11.9×FY 2024: 18.0×
FY 2019 5y median 18.0× FY 2024
Debt / Equity 0.0×
FY 2019: -0.9×FY 2020: -0.4×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
Net Debt / EBITDA 0.1×
FY 2019: -3537×FY 2020: 0.0×FY 2021: 0.8×FY 2022: 0.6×FY 2023: 0.2×FY 2024: 0.1×
FY 2019 5y median 0.2× FY 2024
Interest Coverage 0.0×
FY 2019: -28.6×FY 2020: -19.7×FY 2021: -678×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31